News

Smoking Linked to Many ‘New’ Causes of Death

Author and Disclosure Information

 

References

Smoking causes death from many diseases that until now have not been linked officially to tobacco use, including digestive disorders, liver cirrhosis, infections, renal failure, and breast and prostate cancers, according to a report published online Feb. 11 in the New England Journal of Medicine.

“Our results suggest that the number of persons in the United States who die each year as a result of smoking cigarettes may be substantially greater than currently estimated,” said Brian D. Carter of the epidemiology research program, American Cancer Society, Atlanta, and his associates.

The 2014 Surgeon General’s report estimated that smoking causes more than 480,000 deaths every year in the United States, based on mortality figures from 21 diseases that have been formally established as caused by smoking: 12 types of cancer, 6 types of cardiovascular disease, diabetes, chronic obstructive pulmonary disease, and pneumonia. Mr. Carter and his associates pooled data from five large cohort studies to examine possible associations between smoking and an additional 31 cause-of-death categories. They now estimate that an additional 60,000-120,000 deaths each year can be attributed to smoking.

For their study, the investigators assessed 421,378 men and 532,651 women aged 55 years and older at baseline whose smoking status was carefully recorded and who were followed from 2000 to 2011 in the Cancer Prevention Study II Nutrition Cohort, the Nurses’ Health Study I, the Health Professionals Follow-up Study, the Women’s Health Initiative, and the National Institutes of Health-AARP Diet and Health Study.

As expected, smokers had a twofold to threefold higher mortality from any cause, compared with nonsmokers. Smokers also had a markedly higher risk of death than nonsmokers from all 21 causes already established as attributable to tobacco use, such as lung cancer, oral cancer, ischemic heart disease, atherosclerosis, and stroke. But approximately 17% of smokers’ excess mortality was accounted for by several diseases that previously have not been attributable to tobacco use.

For example, the risk of death due to intestinal ischemia was approximately six times higher among smokers than among nonsmokers, a remarkably strong association that was also reported in the Million Women Study. “Smoking acutely reduces blood flow to the intestines, and evidence suggests that smoking causes risk factors that can often lead to intestinal ischemia, including atherosclerosis, platelet aggregation, and congestive heart failure,” Mr. Carter and his associates said (N. Engl. J. Med. 2015 Feb. 12 [doi:10.1056/NEJMsa140721]). In this study, smoking also more than doubled the risk of dying from other digestive diseases. Previous studies have suggested a link between smoking and digestive disorders such as Crohn’s disease, peptic ulcers, acute pancreatitis, paralytic ileus, bowel obstruction, choletlithiasis, diverticulitis, and gastrointestinal hemorrhage. “Although these diseases are not common causes of death, they account for millions of hospitalizations each year,” the investigators noted.

Continue for mortality risks >>

Pages

Recommended Reading

Fecal Immunochemical Testing, Colonoscopy Found Similar for Detecting Advanced Cancers
Clinician Reviews
CDC: More Can Be Done to Prevent Cervical Cancer Fatalities
Clinician Reviews
Skin Cancer Treatment Costs Skyrocket Over Past Decade
Clinician Reviews
‘Chemo Brain’ May Have Targetable Causes
Clinician Reviews
Conjugated Estrogen Plus Bazedoxifene: A New Approach to Estrogen Therapy
Clinician Reviews
Total Thyroidectomy More Likely With Younger Thyroid Cancer Patients
Clinician Reviews
Breast Cancer Relapse Risk Halved Since 1986
Clinician Reviews
Men on Androgen Deprivation Therapy Not Getting Bisphosphonates
Clinician Reviews
Bronchogenic Squamous Cell Carcinoma With Soft-Tissue Metastasis to the Hand: An Unusual Case Presentation and Review of the Literature
Clinician Reviews
Outcomes of Stage III Colon Cancer Appear Better for Aspirin, COX-2 Inhibitor Users
Clinician Reviews